Article
Non-invasive prenatal testing for dominant single-gene disorders using targeted next-generation sequencing
21 Feb 2025
Abstract excerpt
BACKGROUND: Current non-invasive prenatal testing (NIPT) based on cell-free DNA (cfDNA) mainly targets the detection of chromosome aberrations but not dominant single-gene disorders (dSGDs). AIM: This prospective pilot study aims to evaluate the clinical utility of a plasma cfDNA and targeted next-generation sequencing-based NIPT approach for dSGDs (NIPT-dSGD), with a particular focus on neurodevelopmental...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
